News

FDA approves topical foam for plaque psoriasis of the scalp and body
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
Fierce Pharma2d
FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset
Despite hiring a commercial chief and sponsoring disease awareness efforts last year, Savara will have to wait a while longer ...
Healio1d
FDA grants rare pediatric disease designation for Stargardt disease gene therapy
The FDA granted rare pediatric disease designation for OCU410ST, a gene therapy designed to treat ABCA4-associated ...
Ocugen wins FDA rare pediatric disease status for genetic eye disorder treatment
Ocugen (NASDAQ:OCGN) disclosed on Tuesday that its gene therapy candidate, OCU410ST, has been granted rare pediatric disease ...
Tioga Publishing19h
Olympus secures FDA clearance for most advanced imaging endoscopes
Compared to the previous generation of Olympus scopes, the technology provides improved visibility and less blurring, the ...